Vivet presenting during the 6th annual Gene Therapy for Rare Disorders in Boston

BACK

Vivet will be attending and presenting during the 6th annual Gene Therapy for Rare Disorders in Boston.

https://genetherapy-conference.com/

2022 has undoubtedly been a landmark year for the space with much-needed approvals in the summer marking the first time we have seen multiple approvals in a calendar year from the FDA. Gene Therapy for Rare Disorders 2023 will benchmark these breakthroughs, leverage strategic insights from recent success stories, and bring in-depth insights from experts

During the “Defining Value of Rare Gene Therapies” session, Vivet Therapeutic’s CEO & Co-Founder, Jean-Philippe Combal, will take part in the following panel discussion: “Navigating a Competitive Market & Establishing a Differentiated Product” (March 21, 2pm EST).

Topics to be discussed in this panel discussion will include:

👉 Exploring precompetitive collaboration to support progress to approval

👉 Navigating landscapes where multiple gene therapies are being developed for a specific disease

👉 Understanding value demonstration where standard of care exists and use of RWD to better understand disease severity

 

BACK